• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.82% Nasdaq Up 0.70%

    Cara Therapeutics Inc. (CARA)

    -NasdaqGM
    6.24 Up 0.05(0.81%) May 25, 4:00PM EDT
    Prev Close:6.19
    Open:6.21
    Bid:5.88 x 100
    Ask:6.47 x 1000
    1y Target Est:23.43
    Beta:1.212
    Earnings Date:Aug 8 - Aug 12 (Est.)
    Day's Range:6.11 - 6.35
    52wk Range:4.26 - 23.61
    Volume:391,119
    Avg Vol (3m):788,681
    Market Cap:170.25M
    P/E (ttm):N/A
    EPS (ttm):-1.19
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CARAUp 0.81%170.25M
    PTIEDown 0.43%105.66M
    ABTUp 1.84%56.83B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):50.85
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.72
    Quarterly EPS Est (Jun-16) :-0.42
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback